Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3042]

AORTIC 2021: Goals of AORTIC

Dr Verna Vanderpuye - AORTIC 2021 Programme Director, Ghana

AORTIC 2021: Goals of AORTIC ( Dr Verna Vanderpuye - AORTIC 2021 Programme Director, Ghana )

Advances in prostate cancer in the last 10 years and a glimpse to the future

Prof Laura-Maria Krabbe, Prof Karim Fizazi and Prof Johann De Bono

Advances in prostate cancer in the last 10 years and a glimpse to the future ( Prof Laura-Maria Krabbe, Prof Karim Fizazi and Prof Johann De Bono )

Programme topics at AORTIC 2021 virtual

Dr Abubakar Bello - National Hospital, Abuja, Nigeria

Programme topics at AORTIC 2021 virtual ( Dr Abubakar Bello - National Hospital, Abuja, Nigeria )

WCLC 2021: Epidemiology of MET Exon 14 mutations

Dr Anna Minchom, Dr Alex Spira, Prof Byoung Chul Cho and Prof Albrecht...

WCLC 2021: Epidemiology of MET Exon 14 mutations ( Dr Anna Minchom, Dr Alex Spira, Prof Byoung Chul Cho and Prof Albrecht Stenzinger )

OncoAlert and ecancer weekly round up for October 11th - October 16, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly round up for October 11th - October 16, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

Nivolumab plus chemotherapy or ipilimumab vs chemotherapy as first-line...

Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA

Nivolumab plus chemotherapy or ipilimumab vs chemotherapy as first-line treatment for gastric cancers ( Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA )

ESMO 2021: Latest in EGFR mutated advanced NSCLC

Dr Anna Minchom, Prof Natasha Leighl, Dr Victor Moreno and Dr Carlos Cabrera

ESMO 2021: Latest in EGFR mutated advanced NSCLC ( Dr Anna Minchom, Prof Natasha Leighl, Dr Victor Moreno and Dr Carlos Cabrera )

First-line nivolumab + ipilimumab + chemo in patients with advanced NSCLC and...

Dr David Paul Carbone - The Ohio State University Medical Center, Ohio, USA

First-line nivolumab + ipilimumab + chemo in patients with advanced NSCLC and brain metastases: Results From CheckMate 9LA ( Dr David Paul Carbone - The Ohio State University Medical Center, Ohio, USA )

Trastuzumab deruxtecan vs trastuzumab emtansine in patients with HER2+...

Dr Javier Cortés - Hospital Universitario Ramón y Cajal, Madrid, Spain

Trastuzumab deruxtecan vs trastuzumab emtansine in patients with HER2+ metastatic breast cancer ( Dr Javier Cortés - Hospital Universitario Ramón y Cajal, Madrid, Spain )

ESMO 2021: PARPi data and their role in mono/combination therapies

Dr Neal Shore, Prof Fred Saad, Prof Eleni Efstathiou, Prof Andrew Armstrong

ESMO 2021: PARPi data and their role in mono/combination therapies ( Dr Neal Shore, Prof Fred Saad, Prof Eleni Efstathiou, Prof Andrew Armstrong )

ESMO 2021: Breast cancer roundup

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy

ESMO 2021: Breast cancer roundup ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )

[Vic-]trastuzumab duocarmazine shows improved PFS in pre-treated HER2+ locally...

Dr Cristina Saura - Vall d’Hebron University Hospital, Barcelona, Spain

[Vic-]trastuzumab duocarmazine shows improved PFS in pre-treated HER2+ locally advanced or metastatic breast cancer ( Dr Cristina Saura - Vall d’Hebron University Hospital, Barcelona, Spain )

More from ecancer